DoW Orthopaedic, Clinical Research Award
Open Posted
- Opportunity number
- HT942526ORPCRA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of the Army Medical Command is soliciting applications for the Fiscal Year 2026 Orthopaedic Research Program Clinical Research Award, a competitive grants program that funds clinical research and trials addressing orthopaedic injury and sequelae, with a full application deadline of November 18, 2026 and a pre-application deadline of August 19, 2026.
Eligible applicants include extramural and intramural U.S. Department of War organizations, foreign and domestic organizations, for-profit and nonprofit entities, and public or private entities. Independent investigators at all career levels may serve as Principal Investigator. Cost sharing is not required.
The program offers two research levels. Research Level 1 (RL1) supports clinical research addressing at least one of four focus areas: Ligamentous Trauma, Osseointegration Outcomes, Return-to-Duty Strategies, or Military Women's Health. Research Level 2 (RL2) supports clinical trials addressing at least one of three focus areas: Ligamentous Trauma, Limb Stabilization and Protection, or Return-to-Duty Strategies. RL2 applications must constitute clinical trials with defined study populations, intervention availability, and demonstrated study team expertise.
The program intends to fund approximately two RL1 awards at $2.0 million per award and approximately three RL2 awards at $3.2 million per award. The maximum period of performance is four years for both levels. Awards are anticipated no later than September 30, 2027.
All applications require preliminary and/or published data relevant to the proposed research. Direct cost restrictions prohibit animal research while requiring travel for presentation at a Department of War-sponsored meeting during years 3 or 4. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury. Submissions follow a two-step process through eBRAP for pre-applications and either Grants.gov (extramural) or eBRAP (intramural) for full applications. The program operates under CFDA 12.420 (Military Medical Research and Development).
Synopsis
Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas.
Distinctive Features:
· The CRA offers two research levels.
Research Level 1 (RL1) supports clinical research in the following FY26 ORP focus areas:
· Ligamentous Trauma
· Osseointegration Outcomes
· Return-to-Duty Strategies
· Military Women's Health
Research Level 2 (RL2) supports clinical trials in the following FY26 ORP focus areas:
· Ligamentous Trauma
· Limb Stabilization and Protection
· Return-to-Duty Strategies
Files
| File | Type | Posted |
|---|---|---|
| PKG00293367.pdf | ||
| HT942526ORPCRA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity